Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for Treating Acne of Adult Woman
NCT03334682Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Jan 2018
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of spironolactone in acne vulgaris, sponsored by CHU de Nantes. Started Jan 2018; status: completed.
02
Drugs
spironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT03334682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03334682.